iSpecimen Inc. (ISPC) Quarterly EPS earnings growth

ISPC (iSpecimen Inc) - company brandmark

The quarterly EPS growth history demonstrates the dynamics of iSpecimen Inc. (ISPC), where 94.90 determines the current status of the parameter. The platform's potential for scaling biosamples is constrained by high validation costs. Revenues are based on pharmaceutical R&D budgets and a network of donor centers. Meanwhile, the digital business remains vulnerable due to data nationalism and strict information sovereignty laws in Asia and Europe.

iSpecimen (ISPC) - Year-over-year net earnings per share change for the last twelve months from 07/04/2022 to 11/12/2026

Analytical breakdowns for iSpecimen Inc.

- share price and expert price forecast:
Stock Price ispecimen.com|ISPC - Average Forecast Price
- market capitalization details:
Market Capitalization iSpecimen Corp|ISPC - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Book Value per Share iSpecimen|ISPC - Book Valuation of Business|Market Value to Book Value Ratio ispecimen.com|ISPC - Cumulative Company Assets
- debt and liquidity details:
Total Debt to Capital iSpecimen Inc.|ISPC - Long-Term Liabilities to Capital|Short-Term Debt to Equity ispecimen.com|ISPC - Company Aggregate Debt|Debt to Book Value iSpecimen Corp|ISPC - Company Long-Term Loans and Borrowings|Company Short-Term Debts iSpecimen|Quick Liquidity ispecimen.com
- earnings and valuation multiples indicators:
ISPC - Company Profit|Projected Future Earnings iSpecimen Inc.|ISPC - Price to Earnings Ratio|Projected Price to Earnings ispecimen.com|ISPC - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple iSpecimen Corp|ISPC - Operating income before deduction of amortization|Earnings per share for the last twelve months iSpecimen|ISPC - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months ispecimen.com|ISPC - Earnings per share trend in current year|Earnings growth forecast for next year iSpecimen Inc.
Summary company analysis:iSpecimen Inc, ISPC
Flagship merchandise of ispecimen.com

Investors utilize this metric to evaluate business scaling efficiency and the company's ability to generate real earnings per share. The calculation of the quarterly growth in net income per share reflects profit dynamics net of all expenses, which for iSpecimen Inc. (ISPC) confirms the economic return from the digitalization of the biospecimen marketplace and the optimization of logistical costs within its ESG strategy.

Who iSpecimen Inc. competes with

VEEV: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Doximity Inc (DOCS)|HQY (HealthEquity Corp) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Waystar Corp (WAY)|Quarterly EPS earnings growth CRVL|Year-over-year net earnings per share change for the last twelve months priviahealth.com|Year-over-year earnings per share growth for the last twelve months Huron HURN|CERT - Year-over-year net earnings per share growth for the last 12 months|Omnicell Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months GoodRx Gold|Schrodinger, Inc. (SDGR) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months PHR|Year-over-year net earnings per share growth for the last 12 months OMDA|EVH: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth HSTM|Year-over-year net earnings per share change for the last twelve months Definitive Corp|Year-over-year earnings per share growth for the last twelve months Consensus Cloud Solutions CCSI|AGL: Year-over-year earnings per share growth for the last 12 months|Absci Corporation - Quarterly EPS earnings growth|So-Young International Inc (SY) - Year-over-year net earnings per share growth for the last 12 months|NRC (National Research Corp) - Year-over-year net earnings per share growth for the last 12 months|SPOK - Year-over-year net earnings per share change for the last twelve months|OPRX (OptimizeRx Corporation) - Quarterly EPS earnings growth|trubridge.com (TBRG) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Simulations Plus (SLP)|Year-over-year net earnings per share change for the last twelve months sophiagenetics.com|Year-over-year earnings per share growth for the last twelve months Health Catalyst, Inc HCAT|CCLD (CareCloud Inc.) - Year-over-year net earnings per share trend for the last twelve months|Research Solutions, Inc. - Quarterly EPS earnings growth|DLH Holdings Corp. (DLHC) - Year-over-year net earnings per share growth for the last 12 months|ONMD: Quarterly EPS earnings growth|SCNX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HCTI|BFRG (Bullfrog AI Holdings Inc) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months WORX (SCWorx Corp.)|MSPR (msprecovery.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months iCoreConnect ICCT|MEDS - Year-over-year net earnings per share growth for the last 12 months|Orgenesis Corp - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months R1 RCM Inc.|SHCR: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months STRM|SYRA (Syra Health) - Quarterly EPS earnings growth|ApolloMed (AMEH) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Model N Corp (MODN)|Year-over-year net earnings per share change for the last twelve months NextGen Healthcare Corp